MJP Associates Inc. ADV Takes $212,000 Position in Cigna Group $CI

MJP Associates Inc. ADV purchased a new position in Cigna Group (NYSE:CI) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 642 shares of the health services provider’s stock, valued at approximately $212,000.

Several other hedge funds have also recently added to or reduced their stakes in CI. Cetera Investment Advisers lifted its holdings in Cigna Group by 1.8% in the 2nd quarter. Cetera Investment Advisers now owns 73,405 shares of the health services provider’s stock valued at $24,266,000 after purchasing an additional 1,318 shares in the last quarter. Creative Planning raised its position in shares of Cigna Group by 3.3% in the second quarter. Creative Planning now owns 78,426 shares of the health services provider’s stock valued at $25,926,000 after buying an additional 2,484 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its stake in shares of Cigna Group by 4.6% in the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 65,518 shares of the health services provider’s stock worth $21,659,000 after buying an additional 2,906 shares in the last quarter. Empower Advisory Group LLC boosted its position in Cigna Group by 1.3% during the second quarter. Empower Advisory Group LLC now owns 11,263 shares of the health services provider’s stock worth $3,723,000 after acquiring an additional 143 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA boosted its position in Cigna Group by 1.1% during the second quarter. Massachusetts Financial Services Co. MA now owns 11,778,472 shares of the health services provider’s stock worth $3,893,727,000 after acquiring an additional 123,479 shares during the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Cigna Group

In related news, insider Brian C. Evanko sold 5,368 shares of Cigna Group stock in a transaction that occurred on Friday, October 3rd. The shares were sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the sale, the insider owned 51,182 shares in the company, valued at approximately $15,354,600. This trade represents a 9.49% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO David Cordani bought 4,134 shares of the business’s stock in a transaction on Monday, November 3rd. The stock was purchased at an average cost of $241.88 per share, for a total transaction of $999,931.92. Following the transaction, the chief executive officer owned 157,935 shares of the company’s stock, valued at $38,201,317.80. This trade represents a 2.69% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 0.70% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of analysts have commented on CI shares. Robert W. Baird set a $372.00 price objective on shares of Cigna Group in a report on Thursday, August 14th. Guggenheim dropped their price target on Cigna Group from $350.00 to $309.00 in a research report on Friday, October 31st. Zacks Research downgraded Cigna Group from a “hold” rating to a “strong sell” rating in a research report on Monday, November 3rd. Raymond James Financial reissued a “strong-buy” rating on shares of Cigna Group in a research note on Monday, November 3rd. Finally, Wolfe Research cut their target price on Cigna Group from $345.00 to $325.00 and set an “outperform” rating for the company in a research note on Wednesday, October 15th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $334.05.

Cigna Group Trading Down 0.5%

CI opened at $269.52 on Friday. The stock has a market capitalization of $72.00 billion, a PE ratio of 14.71, a P/E/G ratio of 0.88 and a beta of 0.44. Cigna Group has a one year low of $239.51 and a one year high of $350.00. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71. The business’s 50 day moving average price is $289.75 and its 200 day moving average price is $301.13.

Cigna Group (NYSE:CI) last posted its earnings results on Thursday, October 30th. The health services provider reported $7.83 EPS for the quarter, beating analysts’ consensus estimates of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company had revenue of $69.57 billion for the quarter, compared to the consensus estimate of $66.40 billion. During the same quarter in the previous year, the business earned $7.51 earnings per share. The company’s revenue for the quarter was up 9.5% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, equities research analysts expect that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th will be paid a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend is Thursday, December 4th. Cigna Group’s dividend payout ratio (DPR) is 26.64%.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.